Commodore Capital LP decreased its position in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 30.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 3,275,000 shares of the company’s stock after selling 1,417,809 shares during the quarter. Enliven Therapeutics comprises 7.4% of Commodore Capital LP’s holdings, making the stock its 3rd […]

Commodore Capital LP lessened its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 26.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,475,000 shares of the company’s stock after selling 900,000 shares during the period. Tyra Biosciences makes up 5.5% of […]